US NRC PR on Medical Policy and Regulations

[Mike Grissom <mikeg@SLAC.Stanford.EDU>]

Radsafers,

The following US Nuclear Regulatory Commission press
release should be of general interest (but especially
of interest to the Medical HP Section members).

S.,

MikeG.

----------
Nuclear Regulatory Commission
Office of Public Affairs
Washington DC 20555
Telephone: 301/415-8200 -- E-mail: opa@nrc.gov

No. 98-125
July 23, 1998

   NRC TO HOLD MEETINGS ON PROPOSED REVISIONS
TO MEDICAL POLICY STATEMENT, REGULATIONS

The Nuclear Regulatory Commission will convene public
meetings in San Francisco, Kansas City, and Rockville,
Maryland, over the next few months to obtain comments
on the agency's proposed revisions to its policy
statement and regulations on medical uses of licensed
radioactive material.

The San Francisco meeting will be held on August 19
and 20 at the ANA Hotel San Francisco, 50 Third Street,
San Francisco, California 94103; telephone: 415/974-6400.

The Kansas City meeting will be held on September 16 and
17 at the Radisson Suite Hotel Kansas City, 106 West 12th
Street, Kansas City, Missouri 64105; telephone:
800/333-3333.

The Rockville meeting will be held on October 21 and 22
in the auditorium at the U.S. Nuclear Regulatory
Commission, 11545 Rockville Pike, Rockville, MD
20852-2738.

All three meetings are scheduled for 8:30 a.m. to 5:00
p.m. each day.

Copies of the proposed revisions to the Commission's
medical use policy statement and regulations will be
provided to meeting participants and will be available
for members of the public at the meetings. The proposed
revisions are scheduled to be published in the Federal
Register for public comment in August.

To have a manageable discussion, the number of
participants in each meeting will be limited. Questions
about participation should be directed to the meeting
facilitator, Francis X. Cameron, Special Counsel for
Public Liaison, Office of the General Counsel, Nuclear
Regulatory Commission, Washington, D.C. 20555, telephone:
301/415-1642. Participation is expected by a broad
spectrum of interests that may be affected by the
proposed revisions to the regulations and policy
statement. These interests include: physician specialists,
such as nuclear medicine physicians, radiation
oncologists, cardiologists and radiologists; medical
physicists; medical technologists; nurses; medical
education and certification organizations;
radiopharmaceutical interests; hospital administrators;
radiation safety officers; patients' rights advocates;
states and federal agencies; and experts in risk analysis.
Other members of the public are welcome to attend and
will have an opportunity to participate in the meeting
discussions at periodic intervals.

Written comments on the forthcoming proposed policy
statement and rule revisions may be submitted to the
Secretary, U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001, Attention: Rulemakings and Adjudications
Staff. To ensure consideration, comments should be
received by the dates announced in the Federal Register
notices.

----------
The above may be viewed on the Web at URL:

http://www.nrc.gov/OPA/gmo/nrarcv/98-125.htm